Prelude Capital Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-7,800
| Closed | -$17K | – | 1858 |
|
|
2017
Q3 | $17K | Buy |
7,800
+5,600
| +255% | +$12.2K | ﹤0.01% | 1231 |
|
|
2017
Q2 | $6K | Buy |
+2,200
| New | +$6K | ﹤0.01% | 1338 |
|
|
2016
Q1 | – | Sell |
-2,730
| Closed | -$47K | – | 1722 |
|
|
2015
Q4 | $47K | Hold |
2,730
| – | – | 0.01% | 994 |
|
|
2015
Q3 | $58K | Buy |
2,730
+1,540
| +129% | +$32.7K | 0.01% | 941 |
|
|
2015
Q2 | $59K | Buy |
1,190
+690
| +138% | +$34.2K | 0.01% | 1028 |
|
|
2015
Q1 | $39K | Buy |
+500
| New | +$39K | 0.01% | 1410 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 2263 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2240 |
|